Washington Nationals starting pitcher emphatically denied the initial report regarding the Miami Biogenesis Clinic that linked him to PEDs. The newest report out indicates that Gio was being truthful in his denial. The latest documents links five new players to the Miami clinic and the purchase of PEDs, but clears Gonzalez of purchasing any banned substances. Though not a clear exoneration, it is an excellent indication that Gonzalez will likely not face any MLB discipline.
According to two sources familiar with Bosch's operation, however, the Washington Nationals' Gio Gonzalez, previously identified as being named in Biogenesis documents, did not receive banned substances from Bosch or the clinic.
Both sources, speaking independently, identified Gonzalez as the only Bosch client named thus far who did not receive performance-enhancing drugs. A document obtained by "Outside the Lines" bolsters their case: On a computer printout of clients, Gonzalez, identified by the code name "Gladiator," is said to have received $1,000 worth of substances, but under "notes" are several substances not banned by Major League Baseball: "gluthetyn" (which a source said was a misspelling of glutathione), "IM [intramuscular] shots," and amino acids.
More than likely, Major League Baseball may have already seen the documents and possibly knew of no link between Gio and the acquisition of PEds. Gonzalez was selected by Team USA manager Joe Torre, who holds a high position within Major League Baseball administration, to join the team for the World Baseball Classic. It is hard to believe that Torre would have added Gonzalez if he had information linking Gonzalez to PEDs that would result in a major league baseball suspension. Torre is in a position to know.